Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder

NCT06373016 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT06373016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06373016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
Lead sponsor
Stony Brook University
Phase
Not applicable
Overall status
Recruiting
Start date
January 26, 2024
Completion date
February 1, 2027
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, bipolar disorder type 1